Sagimet Biosciences announced the appointment of Thierry Chauche as Chief Financial Officer, effective today, May 6, 2024. Most recently Chauche served as Chief Financial Officer of Provention Bio
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGMT:
- Sagimet Biosciences Announces Appointment of Thierry Chauche as Chief Financial Officer
- Carvana upgraded, Block downgraded: Wall Street’s top analyst calls
- Sagimet Biosciences initiated with a Buy at H.C. Wainwright
- Sagimet Biosciences Announces Completion of Phase 1 Hepatic Impairment Study with FASN Inhibitor Denifanstat
- Sagimet Biosciences appoints Tim Walbert, Paul Hoelscher to board of directors